Statin use linked to reduced risk of hepatocellular cancer

Statin use linked to reduced risk of hepatocellular cancer
Statin use is associated with a reduced risk of hepatocellular carcinoma, most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

(HealthDay)—Statin use is associated with a reduced risk of hepatocellular carcinoma (HCC), most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

Siddharth Singh, M.B.B.S., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a systematic literature review and meta-analysis of studies that evaluated the effects of statins on the risk of HCC. The analysis included 10 studies reporting 4,298 cases of HCC in 1,459,417 patients.

The researchers found that, compared with statin nonusers, statin users were significantly less likely to develop HCC (adjusted odds ratio [aOR], 0.63), although there was considerable heterogeneity in the results (P = 0.01; I² = 59 percent). Suggested sources of this heterogeneity included study location (Asian population [four studies]: aOR, 0.52; Western population [six studies]: aOR, 0.67) and study design ( [seven studies]: aOR, 0.60; clinical trials [three studies]: aOR, 0.95; 95 percent confidence interval, 0.62 to 1.45).

"In summary, our meta-analysis suggests that use of statins is associated with a reduced risk of HCC," the authors write. "However, these results should be interpreted with caution given the possibility of residual confounding. Future randomized clinical trials or prospective cohort studies in populations at high risk for HCC (especially in the Asian -infected population) are warranted."

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Hepatitis B virus mutations may predict risk of liver cancer

Jul 02, 2009

Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a ...

Study indicates cancer preventive effect for statins

May 05, 2009

The commonly used prescription statin drugs may have a protective effect in the prevention of liver cancer and lead to a reduction in the need for gallbladder removals, according to two studies published in Gastroenterology. As mil ...

Recommended for you

Scientists zero in on how lung cancer spreads

17 hours ago

Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells - meaning they can break loose and spread, according to ...

Scientists identify rare cancer's genetic pathways

20 hours ago

An international research team, including four Simon Fraser University scientists, has identified the "mutational landscape" of intrahepatic cholangiocarcinoma (ICC), a rare, highly fatal form of liver cancer that disproportionately ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.